The main dispute is broadly between developed and developing countries. Negotiating blocs such as the Group for Equity and the Africa Group want a standard contract that makes it mandatory for pharmaceutical companies to share any medical products developed as a result of countries sharing dangerous pathogens with them.

Several European countries have argued this could stifle research and development and reportedly proposed a hybrid model, with a mix of mandatory and voluntary requirements.

It’s all about the monieeeeesssss